Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue.

Saved in:
Bibliographic Details
Title: Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issue.
Authors: Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Deiana C; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Galvani L; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Ricci AD; Medical Oncology Unit, National Institute of Gastroenterology, 'Saverio de Bellis' Research Hospital, Bari, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Struttura Semplice Dipartimentale di Oncologia Medica per la Presa in Carico Globale del Paziente Oncologico 'Don Tonino Bello', Bari, Italy., Tavolari S; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medicine and Surgical Sciences, University of Bologna, Bologna, Italy.
Source: Frontiers in oncology [Front Oncol] 2023 Apr 24; Vol. 13, pp. 1137510. Date of Electronic Publication: 2023 Apr 24 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first